Nano Nuclear Energy Inc.
For the period ended Sep 30, 2025. Filed Dec 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Dec 18, 2025
NNE$12.48+12.3%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Year Ended September 30, 2025 | For the Year Ended September 30, 2024 | |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net loss | $(40,067,076) | $(10,151,556) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Equity-based compensation | 18,824,215 | 320,257 |
| Amortization of right-of-use assets | 295,576 | 96,532 |
| Depreciation | 355,162 | 10,393 |
| R&D acquisition paid-in equity | - | 786,500 |
| Changes in fair value of contingent liability | 1,207,500 | - |
| Change in assets and liabilities: | ||
| Prepaid expenses | (68,914) | (628,090) |
| Deposits | (284,000) | (235,235) |
| Accounts receivable | (250,000) | - |
| Accounts payable and accrued liabilities | 553,115 | 571,474 |
| Due to related parties | (25,000) | (10,000) |
| Lease liabilities | (162,541) | 5,079 |
| Contingent liability | - | 770,500 |
| Net cash used in operating activities | (19,621,963) | (8,464,146) |
| INVESTING ACTIVITIES | ||
| In-process research and development | (9,075,045) | - |
| Increase in long-term investments | - | (2,000,000) |
| Additions to property, plant and equipment | (8,449,332) | (1,700,000) |
| Net cash used in investing activities | (17,524,377) | (3,700,000) |
| FINANCING ACTIVITIES | ||
| Proceeds from common stock issuances | 206,400,015 | 34,953,937 |
| Offering costs | (15,076,556) | (3,554,829) |
| Proceeds from exercise of warrants | 18,476,176 | 1,275,500 |
| Proceeds from exercise of stock options | 2,404,500 | 1,044,000 |
| Payment of deferred offering costs | (300,000) | - |
| Net cash provided by financing activities | 211,904,135 | 33,718,608 |
| Net increase in cash | 174,757,795 | 21,554,462 |
| Cash and cash equivalents, beginning of year | 28,507,257 | 6,952,795 |
| Cash and cash equivalents, end of year | $203,265,052 | $28,507,257 |
| Non-Cash Supplemental Disclosures | ||
| Inception of Right-of-Use Asset / Lease Liability | $1,026,348 | $1,926,178 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.